Oscar Health (OSCR) Could Be 95% Below Fair Value After Raised 2026 Guidance

Simply Wall St.

08/12

AdvertisementWhy Oscar Health Stock Is Back in Focus After Guidance Shift Oscar Health (OSCR) is back on many investors’ watchlists after Q2 2026 earnings beat market expectations and the company ...

网页链接

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2658419912"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2658419912\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2658419912?lang=zh_CN&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/7212000-choice1-main-header/1585186806799","is_english":true,"pubTime":"2026-08-12 00:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2658419912","market":"nz","top_or_hot":-1,"title":"Oscar Health (OSCR) Could Be 95% Below Fair Value After Raised 2026 Guidance","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy Oscar Health Stock Is Back in Focus After Guidance Shift Oscar Health (OSCR) is back on many investors’ watchlists after Q2 2026 earnings beat market expectations and the company ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-could-be-95-below-fair-value-after-raised\">网页链接</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oscar Health (OSCR) Could Be 95% Below Fair Value After Raised 2026 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOscar Health (OSCR) Could Be 95% Below Fair Value After Raised 2026 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-12 00:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-could-be-95-below-fair-value-after-raised><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy Oscar Health Stock Is Back in Focus After Guidance Shift Oscar Health (OSCR) is back on many investors’ watchlists after Q2 2026 earnings beat market expectations and the company ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-could-be-95-below-fair-value-after-raised\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4162","symbol_name":"人寿与健康保险","start_time":0,"source_url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-could-be-95-below-fair-value-after-raised","article_id":"2658419912","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/7212000-choice1-main-header/1585186806799"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/insurance/nyse-oscr/oscar-health/news/oscar-health-oscr-could-be-95-below-fair-value-after-raised","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2658419912","pubTimestamp":1786465687,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why Oscar Health Stock Is Back in Focus After Guidance Shift\nOscar Health (OSCR) is back on many investors’ watchlists after Q2 2026 earnings beat market expectations and the company raised its full year 2026 revenue and earnings guidance.\nSee our latest analysis for Oscar Health.\nThe raised guidance and stronger Q2 earnings have come after a sharp run in Oscar Health’s share price, with a year to date share price return of 84.84% and a three year total shareholder return of 298.70%. This is...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4162":"人寿与健康保险","OSCX":"2倍做多OSCR ETF-Defiance","HEAL":"Global X HealthTech ETF","BK4551":"寇图资本持仓","OSCG":"2倍做多OSCR ETF-Leverage Shares","OSCR":"Oscar Health, Inc."},"translate_title":"Oscar Health (OSCR) 在上调 2026 年指引后可能比公允价值低 95%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1.98,"OSCG":0.6,"OSCX":0.6,"HEAL":0.6},"content_text":"AdvertisementWhy Oscar Health Stock Is Back in Focus After Guidance Shift Oscar Health (OSCR) is back on many investors’ watchlists after Q2 2026 earnings beat market expectations and the company raised its full year 2026 revenue and earnings guidance. See our latest analysis for Oscar Health. The raised guidance and stronger Q2 earnings have come after a sharp run in Oscar Health’s share price, with a year to date share price return of 84.84% and a three year total shareholder return of 298.70%. This is despite the stock recently pulling back 9.40% over the past 30 days and 9.99% over the past week. If Oscar Health’s use of AI in healthcare has caught your attention, it can be useful to see what else is out there and review the 43 healthcare AI stocks. Oscar Health now trades only slightly below the average analyst price target after a very strong run and fresh guidance. Is the market still too cautious, or is it already pricing this rebound fairly as investors look at valuation next? Most Popular Narrative: 95% Undervalued According to the most followed Oscar Health narrative, the gap between the last close at $27.67 and a fair value of $583.34 is extremely wide, which sharply contrasts with the relatively tight analyst price target of $28.20.  Suspicious of a value trap, I started digging into the operational engine to find the catch. Instead, the deeper I dug, the more the moat began to show. Capital Efficiency: The business generates a powerful 27.9% return on invested capital (ROIC), even while operating on a razor thin 4.1% operating margin.  Read the complete narrative. Curious how a health insurer ends up with a triple digit fair value estimate? The narrative leans heavily on compounding growth, rising margins and a punchy profit multiple. Want to see which specific cash flow and return assumptions connect that story to a fair value above $500? Result: Fair Value of $583.34 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this Oscar Health narrative depends on very optimistic growth and margin assumptions, and any setback in cash generation or regulation could quickly challenge that story. Find out about the key risks to this Oscar Health narrative. Another View on Oscar Health’s Valuation The user narrative leans heavily on a DCF result that puts Oscar Health’s fair value far above the current $27.67 share price. Yet on simpler yardsticks, the stock already looks full. Oscar Health trades on a P/E of 15.5x, which is higher than both the US Insurance industry at 11.6x and its peer group at 12.9x. At the same time, that 15.5x P/E is below a fair ratio of 23.4x that our regression suggests the market could move toward. For you as an investor, that mix of premium pricing versus today’s peers and a lower P/E than the fair ratio raises a practical question: Is this a margin of safety or a signal that expectations are already demanding? See what the numbers say about this price — find out in our valuation breakdown. NYSE:OSCR P/E Ratio as at Aug 2026Next Steps With both the optimism around Oscar Health and the reservations about its valuation on the table, it makes sense to look at the full picture yourself and move quickly while sentiment is active. To weigh up both sides of the story in one place, review the 3 key rewards and 2 important warning signs. Looking for more Oscar Health style investment ideas? If Oscar Health has sharpened your focus, do not stop here. The Simply Wall Street Screener can quickly surface more stocks that fit what you are looking for.  Target underappreciated quality and let the screener highlight companies that combine strong fundamentals with attractive valuations through the screener containing 21 high quality undiscovered gems. Prioritise resilience and use the screener to spot companies that pair solid balance sheets with dependable fundamentals using the solid balance sheet and fundamentals stocks screener (48 results). Reduce unpleasant surprises by focusing on companies that our models flag with lower risk profiles through the 83 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}